Literature DB >> 4546938

T lymphocytes in bladder and prostatic cancer patients.

W J Catalona, C Potvin, P B Chretien.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4546938     DOI: 10.1016/s0022-5347(17)59735-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  8 in total

1.  Lymphocyte subsets in urologic cancer patients.

Authors:  M Shaw; P Ray; M Rubenstein; P Guinan
Journal:  Urol Res       Date:  1987

2.  T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.

Authors:  R J Rand; D M Jenkins; R Bulmer
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

3.  Restoration of E-rosette formation by bestatin in patients with bladder cancer.

Authors:  H Yokoyama; T Umeda; K Kobayashi; H Akaza; T Niijima
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  The Makari skin test and immunocompetence in bladder cancer.

Authors:  J R Masters; C C Rigby; K W Munson; D E Tee
Journal:  Urol Res       Date:  1980

5.  E-rosette forming cell numbers in the blood of human renal allograft recipients.

Authors:  G E Kelly; A G Sheil
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

6.  Immunological studies of patients with tumours of the prostate and bladder (a retrospective analysis).

Authors:  I Romics; J Fehér; J Horváth
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

7.  Evaluation of the immunocompetance of patients with transitional cell carcinoma of the bladder.

Authors:  H D Adolphs; L Steffens
Journal:  Urol Res       Date:  1977

8.  E-rosette-forming cells at 29 degrees C: an assay for the evaluation of the immune status of cancer patients.

Authors:  P C Quan; P Burtin
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.